{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T01:18:16Z","timestamp":1766711896973,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T00:00:00Z","timestamp":1428624000000},"content-version":"vor","delay-in-days":3812,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.bbmt.2004.07.010","type":"journal-article","created":{"date-parts":[[2004,10,23]],"date-time":"2004-10-23T23:07:12Z","timestamp":1098572832000},"page":"805-812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation"],"prefix":"10.1016","volume":"10","author":[{"given":"Hai","family":"Tran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrios","family":"Petropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Worth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Craig A.","family":"Mullen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy","family":"Madden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borje","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Choroszy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susannah K.","family":"Webb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ka Wah","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbmt.2004.07.010_bib1","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/bbmt.2002.v8.pm12374452","article-title":"Busulfan systemic exposure relative to regimen-related toxicity and acute graft-versus-host disease","volume":"8","author":"Andersson","year":"2002","journal-title":"Biol Blood Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/sj.bmt.1703612","article-title":"Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation","volume":"30","author":"McCune","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib3","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00688324","article-title":"Busulfan disposition and hepatic veno-occlusive disease in children undergoing bone marrow transplantation","volume":"37","author":"Vassal","year":"1996","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.bbmt.2004.07.010_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s00280-003-0631-y","article-title":"Population pharmacokinetics of oral busulfan in children","volume":"52","author":"Schiltmeyer","year":"2003","journal-title":"Cancer Chemother Pharmacol."},{"key":"10.1016\/j.bbmt.2004.07.010_bib5","first-page":"5509","article-title":"Age-dependent tetrahydrothiophenium ion formation in young children and adults receiving high-dose busulfan","volume":"57","author":"Gibbs","year":"1997","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbmt.2004.07.010_bib6","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/sj.bmt.1702561","article-title":"Individualizing high-dose oral busulfan","volume":"26","author":"Tran","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib7","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.bmt.1703207","article-title":"Improved clinical outcome of pediatric bone marrow recipients using a test dose and Bayesian pharmacokinetic individualization of busulfan dosage regimens","volume":"28","author":"Bleyzac","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/sj.bmt.1703264","article-title":"Target dose adjustment of busulfan in pediatric patients undergoing bone marrow transplantation","volume":"28","author":"Bolinger","year":"2001","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib9","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/S1083-8791(00)70064-4","article-title":"Acute safety and pharmacokinetics of intravenous busulfan when used with oral busulfan and cyclophosphamide as pretransplantation conditioning therapy","volume":"6","author":"Andersson","year":"2000","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/bbmt.2002.v8.pm11939604","article-title":"Conditioning therapy with intravenous busulfan and cyclophosphamide (IV BuCy2) for hematologic malignancies prior to allogeneic stem cell transplantation","volume":"8","author":"Andersson","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib11","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/sj.bmt.1703593","article-title":"Lorazepam for seizure prophylaxis during high-dose busulfan administration","volume":"29","author":"Chan","year":"2002","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib12","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1038\/sj.bmt.1701807","article-title":"Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation","volume":"23","author":"Przepiorka","year":"1999","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib13","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1200\/JCO.1988.6.10.1562","article-title":"Regimen-related toxicity in patients undergoing bone marrow transplantation","volume":"6","author":"Bearman","year":"1988","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.bbmt.2004.07.010_bib14","first-page":"867","article-title":"Development of a simple probe for documentation of chimerism following bone marrow transplantation","volume":"41","author":"Yam","year":"1987","journal-title":"Am J Hum Genet."},{"key":"10.1016\/j.bbmt.2004.07.010_bib15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc."},{"key":"10.1016\/j.bbmt.2004.07.010_bib16","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1214\/aoms\/1177730491","article-title":"On a test whether one of two random variables is stochastically larger than the other","volume":"18","author":"Mann","year":"1947","journal-title":"Ann Math Stat."},{"key":"10.1016\/j.bbmt.2004.07.010_bib17","doi-asserted-by":"crossref","first-page":"80","DOI":"10.2307\/3001968","article-title":"Individual comparisons by ranking methods","volume":"1","author":"Wilcoxon","year":"1945","journal-title":"Biometr Bull."},{"key":"10.1016\/j.bbmt.2004.07.010_bib18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0378-4347(01)00356-5","article-title":"Quantification of busulfan in plasma by liquid chromatography-ion spray mass spectrometry. Application to pharmacokinetic studies in children","volume":"763","author":"Quernin","year":"2001","journal-title":"J Chromatogr B Biomed Sci Appl."},{"key":"10.1016\/j.bbmt.2004.07.010_bib19","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0010-468X(79)90025-4","article-title":"A program package for simulation and parameter estimation in pharmacokinetics","volume":"9","author":"D\u2019Argenio","year":"1979","journal-title":"Comput Programs Biomed."},{"key":"10.1016\/j.bbmt.2004.07.010_bib20","first-page":"480a","article-title":"Phase II trial of intravenous busulfan (Busulfex\u00ae) with cyclophosphamide in pediatric allogeneic hematopoietic cell transplantation: pharmacokinetics, toxicity and efficiency. A Pediatric Blood and Marrow Transplant Consortium study","volume":"96","author":"Wall","year":"2000","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/j.bbmt.2004.07.010_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.bbmt.2003.12.122","article-title":"Frequency and magnitude of dose adjustment of IV busulfan in targeted dosing strategy for pediatric allogeneic transplantation","volume":"10","author":"Grimley","year":"2004","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-2125.2002.01555.x","article-title":"Pharmacokinetics of intravenous busulfan in children prior to stem cell transplantation","volume":"53","author":"Cremers","year":"2002","journal-title":"Br J Clin Pharmacol."},{"key":"10.1016\/j.bbmt.2004.07.010_bib23","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/sj.bmt.1704209","article-title":"Intravenous busulfan for allogeneic stem cell transplantation in infants","volume":"32","author":"Dalle","year":"2003","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib24","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/sj.bmt.1700891","article-title":"An improved limited sampling method for individualised busulfan dosing in bone marrow transplantation in children","volume":"20","author":"Chattergoon","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib25","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1053\/bbmt.2002.v8.pm12374453","article-title":"Evaluation of safety and pharmacokinetics of administering intravenous busulfan in a twice-daily or daily schedule to patients with advanced hematologic malignant disease undergoing stem cell transplantation","volume":"8","author":"Fernandez","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib26","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1053\/bbmt.2002.v8.pm12374451","article-title":"Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation","volume":"8","author":"Russell","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib27","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1097\/00043426-200310000-00019","article-title":"Fludarabine and once-daily intravenous busulfan for allogeneic bone marrow transplantation for Chediak-Higashi syndrome","volume":"25","author":"Gordon","year":"2003","journal-title":"J Pediatr Hematol Oncol."},{"key":"10.1016\/j.bbmt.2004.07.010_bib28","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1053\/bbmt.2002.v8.pm12374454","article-title":"Intravenous versus oral busulfan as part of a busulfan\/cyclophosphamide preparative regimen for allogeneic hematopoietic stem cell transplantation","volume":"8","author":"Kashyap","year":"2002","journal-title":"Biol Blood Marrow Transplant."},{"key":"10.1016\/j.bbmt.2004.07.010_bib29","doi-asserted-by":"crossref","first-page":"2962","DOI":"10.1182\/blood.V97.10.2962","article-title":"Comparison of outcomes of unrelated bone marrow and umbilical cord blood transplants in children with acute leukemia","volume":"97","author":"Rocha","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.bbmt.2004.07.010_bib30","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1053\/bbmt.2002.v8.pm12374450","article-title":"Parenteral busulfan","volume":"8","author":"Grochow","year":"2002","journal-title":"Biol Blood Marrow Transplant."}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104004252?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879104004252?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:21:32Z","timestamp":1761056492000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879104004252"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S1083879104004252"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.07.010","relation":{},"ISSN":["1083-8791"],"issn-type":[{"type":"print","value":"1083-8791"}],"subject":[],"published":{"date-parts":[[2004,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacokinetics and individualized dose adjustment of intravenous busulfan in children with advanced hematologic malignancies undergoing allogeneic stem cell transplantation","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2004.07.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2004 American Society for Blood and Marrow Transplantation. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}